home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Biopharmaceutical Analytics: From Development to Validation

  December 02, 2016  
CfPA-The Center for Professional Advancement, Amsterdam, The Netherlands
24-25 April 2017

Who Should Attend?
This course is designed to provide training to biopharmaceutical personnel on the purpose and functions of an analytical program, strategies for analytical testing (from developing a method through validation), select characterization methods, and quality systems essential for an analytical group. This course is recommended for:

  • Quality Control, Quality Assurance
  • Analytical Scientist
  • Research Associates
  • Engineers and Administrators working in analytical development, Product 
     Development, Manufacturing, Validation, Formulation, and Pre-formulation 
     groups, though any inquiring minds within this industry are welcome to join

Course Description
This intensive, 2-day course will take participants on a journey showing the different functions and responsibilities required by an analytical group through all the stages of drug development. It will begin with understanding regulations to build a foundation of how a compliant lab and strong methods should be built, then will continue through the evolution of the test methods and functionality of an analytical group through the method validation stage. Throughout this journey different strategies for developing, assessing, qualifying and validating test methods to meet ICH guidelines will be examined. Select characterization methods, new technologies and how they fit into an analytical program will also be evaluated. 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
Rachel Monsef, Consultant to the pharmaceutical and biopharmaceutical industries

Rachel Monsef is an analytical chemist in the pharmaceutical industry who has 16 years’ experience working with many types of assays for all stages of drug development. She has worked on several projects that required method development all the way through method validations. She has experience with assay transfer, characterization work, and stability studies. She has also worked with manufacturing groups to develop and perform assays to support their efforts. She has previously worked for Seattle Genetics, Nastech and has had many different roles at Alder Biopharmaceuticals where she is currently acting as a quality control consultant.

Ms. Monsef received her Bachelor of Science in Chemistry from the University of Washington.
Deadline for Abstracts: N/A
Registration: Please click here for registration information.
E-mail: Jmorbit@cfpa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.